Anteris Technologies (AU:AVR) has released an update.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Anteris Technologies Global Corp., a leader in structural heart innovations, has filed a report with the SEC related to their schemes of arrangement. The company is renowned for its DurAVR® Transcatheter Heart Valve, which mimics a healthy aortic valve to treat aortic stenosis. Their patented ADAPT® tissue technology has been successfully used in over 55,000 patients worldwide.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.